Top 5 InsurTech Startup Investors in Mali in January 2026

Last updated: Jan 2026 A list of 5 angel investors and VC (Venture Capital) funds that invest in Insurtech startups based in Mali. We rank investors based on the number of investments they made in Insurtech companies from Mali. We update this investor list every month.

Top 5 InsurTech Startup Investors in Mali in January 2026

Investor	InsurTech Mali investments
ImpactAssets	1
Newfund	1
Lionel Dorie	1
Resilience	1
Mercy Corps Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

ImpactAssets is the preeminent partner for impact investing and philanthropic giving for individuals, families and a range of organizations that want to create positive change for the world.

Investment focus

Software, Health Care, Biotechnology
Seed, Series A, Pre-Seed
United States, India, Mali

Portfolio highlights

Mad capital — Mad Capital is not your normal lender.
Affinity — Join over 100,000 who trust the Affinity mobile app to manage their banking needs, from savings to payments, as well as instant loans
Alpha Design AI — Alpha Design AI is reinventing semiconductor design and verification through advanced AI agent techniques. Alpha Design AI is pioneering an AI-native approach to Electronic Design Automation (EDA), transforming how chips are designed and verified. Our flagship product, ChipAgents, aims to boost RTL design and verification productivity by 10x,driving innovation across industries with smarter, more efficient chip design.

Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.

Investment focus

Software, Information Technology, SaaS
Seed, Funding Round, Series A
France, United States, Canada

Portfolio highlights

Evera — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
Reecall — Reecall is an IT firm that provides AI-based call management services.
Nucleon Security — Nucleon Security is a cybersecurity software company that develops advanced, AI-powered endpoint protection solutions based on Zero Trust principles. Our mission is to help organizations of all sizes detect, prevent, and respond to cyber threats in real time—without compromising performance, usability, or sovereignty.At the core of our offeringis Nucleon EDR, a next-generation Endpoint Detection & Response platform designed to provide deep visibility, proactive defense, and automated response capabilities. Complemented by our MDR (Managed Detection & Response) services and Malprob, our malware detonation sandbox, we deliver a comprehensive security stack that adapts to evolving threat landscapes.Headquartered in France with operations across Europe and Africa, Nucleon Security partners with critical infrastructure, governments, and enterprises to strengthen their cyber resilience and accelerate secure digital transformation.

Lionel Dorie founding partner of Augusta Energy Group.

Investment focus

AgTech, InsurTech, Mobile Payments
Seed
Mali

Portfolio highlights

OKO — New generation crop insurance designed for emerging markets Droughts and flood insurance available from any mobile phone in Mali

We're changing the way medicine is made - leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.

Investment focus

Biotechnology, B2B, IaaS
Seed, Series A, Series B
United States, Mali, United Kingdom

Portfolio highlights

bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
PartnerSlate — Matching pre-qualified CPG brands with compatible co-manufacturers for over a decade, PartnerSlate makes reaching production faster and easier than ever.
Cellevolve Bio — Cellevolve Bio is a development and commercialization company focused on cell therapies.

Our impact investing arm, Mercy Corps Ventures (MCV), invests in and fuels high-impact enterprises that increase the resilience of people and communities in frontier markets.